150 related articles for article (PubMed ID: 32861282)
21. [Mantle cell lymphoma: case report].
Méhes L; Telek B; Udvardy M; Schlammadinger A; és Rejto L
Orv Hetil; 2008 Aug; 149(31):1471-4. PubMed ID: 18632508
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma.
Albano D; Bosio G; Bianchetti N; Pagani C; Re A; Tucci A; Giubbini R; Bertagna F
Ann Nucl Med; 2019 Jul; 33(7):449-458. PubMed ID: 30929200
[TBL] [Abstract][Full Text] [Related]
23. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
[TBL] [Abstract][Full Text] [Related]
24. Smoldering mantle cell lymphoma.
Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML
J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179
[TBL] [Abstract][Full Text] [Related]
25. Radiomic features of glucose metabolism enable prediction of outcome in mantle cell lymphoma.
Mayerhoefer ME; Riedl CC; Kumar A; Gibbs P; Weber M; Tal I; Schilksy J; Schöder H
Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2760-2769. PubMed ID: 31286200
[TBL] [Abstract][Full Text] [Related]
26. A British Society for haematology good practice paper on the diagnosis and investigation of patients with mantle cell lymphoma.
McKay P; Leach M; Jackson B; Robinson S; Rule S
Br J Haematol; 2018 Jul; 182(1):63-70. PubMed ID: 29882587
[No Abstract] [Full Text] [Related]
27. Watch and Wait in Mantle Cell Lymphoma.
Lee C; Martin P
Hematol Oncol Clin North Am; 2020 Oct; 34(5):837-847. PubMed ID: 32861281
[TBL] [Abstract][Full Text] [Related]
28. A pilot study to evaluate 3'-deoxy-3'-18F-fluorothymidine pet for initial and early response imaging in mantle cell lymphoma.
Herrmann K; Buck AK; Schuster T; Rudelius M; Wester HJ; Graf N; Scheuerer C; Peschel C; Schwaiger M; Dechow T; Keller U
J Nucl Med; 2011 Dec; 52(12):1898-902. PubMed ID: 22065875
[TBL] [Abstract][Full Text] [Related]
29. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
30. Mantle cell lymphoma presenting as bilateral adrenal huge masses.
Doroudinia A; Bakhshayesh Karam M; Ranjbar M; Nikmanesh A; Mehrian P
BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29666081
[TBL] [Abstract][Full Text] [Related]
31. Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility.
Guidot DM; Switchenko JM; Nastoupil LJ; Koff JL; Blum KA; Maly J; Flowers CR; Cohen JB
Leuk Lymphoma; 2018 Apr; 59(4):888-895. PubMed ID: 28797213
[TBL] [Abstract][Full Text] [Related]
32. A subset of CD45+/CD19 - cells in bone marrow may be associated with clinical outcomes of patients with mantle cell lymphoma.
Kim SM; Lee ST; Ryu KJ; Kim HJ; Kim SH; Ko YH; Kim WS; Kim SJ
Leuk Lymphoma; 2015; 56(11):3052-7. PubMed ID: 25739938
[TBL] [Abstract][Full Text] [Related]
33. Mantle cell lymphoma: biological insights and treatment advances.
Leonard JP; Williams ME; Goy A; Grant S; Pfreundschuh M; Rosen ST; Sweetenham JW
Clin Lymphoma Myeloma; 2009 Aug; 9(4):267-77. PubMed ID: 19717376
[TBL] [Abstract][Full Text] [Related]
34. Radiotherapy in mantle cell lymphoma: A literature review.
Ben Barouch S; Kuruvilla J; Tsang RW; Yashphe E; Sarid N
Hematol Oncol; 2020 Aug; 38(3):223-228. PubMed ID: 31873945
[TBL] [Abstract][Full Text] [Related]
35. Bilateral Renal Involvement in Mantle Cell Lymphoma on FDG PET/CT.
Mukherjee A; Agarwal KK; Gogia A; Bal C; Kumar R
Clin Nucl Med; 2016 Apr; 41(4):e206-7. PubMed ID: 26914553
[TBL] [Abstract][Full Text] [Related]
36. Mantle Cell Lymphoma with t(11;22) (q13;q11.2) an indolent clinical variant?
Marrero WD; Cruz-Chacón A; Cabanillas F
Leuk Lymphoma; 2018 Oct; 59(10):2509-2511. PubMed ID: 29415598
[No Abstract] [Full Text] [Related]
37. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis.
Saksena A; Yin CC; Xu J; Li J; Zhou J; Wang SA; Lin P; Tang G; Wang L; Wang M; Miranda RN; Medeiros LJ; Li S
Hum Pathol; 2019 Jul; 89():71-80. PubMed ID: 31054894
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort.
Knudsen MKH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
JAMA Ophthalmol; 2017 Dec; 135(12):1367-1374. PubMed ID: 29121219
[TBL] [Abstract][Full Text] [Related]
39. Autotransplantation for mantle cell lymphoma.
Vose JM
Cancer J; 2012; 18(5):427-31. PubMed ID: 23006947
[TBL] [Abstract][Full Text] [Related]
40. 18F-FDG PET/CT in Intramuscular Mantle Cell Lymphoma With Elongated Lymphomatous Neurovascular Extension.
Hod N; Levin D; Anconina R; Ezroh Kazap D; Lantsberg S
Clin Nucl Med; 2019 Apr; 44(4):e298-e300. PubMed ID: 30688737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
